Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone
- PMID: 8744555
- DOI: 10.1016/0264-410x(95)00201-b
Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone
Abstract
Pertussis toxin (Ptx), the major toxin product of Bordetella pertussis, has potent immunologic effect including adjuvant effects on antibody responses and sensitization for anaphylaxis. In order to further define the effect of Ptx on the class and subclass of murine antibody response, we measured total and antigen specific IgG subclasses and IgE in Balb/c mice after primary and secondary immunization with tetanus toxoid (TT). Low doses of Ptx (100 ng) given intravenously at the time of primary immunization increased primary IgG1 and IgE anti-TT antibodies as well as total IgG1 and IgE concentrations compared to controls. The increase in IgG1 subclass and IgE response when Ptx was present during primary immunization was even more pronounced after secondary immunization with TT alone 3 weeks or 3 months later. Similar effects were noted after diphtheria toxoid immunization in the presence of Ptx. Administration of the anti IL-4 monoclonal antibody (11B11) suppressed the enhanced total and TT-specific IgE responses but not the enhanced IgG1 responses. The presence of low concentrations of Ptx during primary immunization primes for induction of IL-4 producing T-cell help which enhances IgGI and IgE responses to the primary exposure as well as to subsequent exposures of the antigen in the absence of Ptx. This phenomenon may have significance for the adjuvant activity of vaccines containing Ptx as well as for the immune response to natural pertussis.
Similar articles
-
A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteins.Infect Immun. 1995 Jun;63(6):2100-8. doi: 10.1128/iai.63.6.2100-2108.1995. Infect Immun. 1995. PMID: 7768587 Free PMC article.
-
Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.Vaccine. 2003 Mar 7;21(11-12):1165-73. doi: 10.1016/s0264-410x(02)00516-9. Vaccine. 2003. PMID: 12559794
-
Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.Biologicals. 1994 Mar;22(1):53-63. doi: 10.1006/biol.1994.1008. Biologicals. 1994. PMID: 8068314
-
[The immunological basis of the administration of DTP-polio vaccine].Verh K Acad Geneeskd Belg. 2000;62(4):245-67. Verh K Acad Geneeskd Belg. 2000. PMID: 11004905 Review. Dutch.
-
Stimuli for the production and control of IgE in rats.Immunol Rev. 1978;41:52-76. doi: 10.1111/j.1600-065x.1978.tb01460.x. Immunol Rev. 1978. PMID: 360512 Review.
Cited by
-
Bordetella bronchiseptica is a potent and safe adjuvant that enhances the antigen-presenting capability of dendritic cells.Korean J Physiol Pharmacol. 2020 Jan;24(1):47-52. doi: 10.4196/kjpp.2020.24.1.47. Epub 2020 Dec 20. Korean J Physiol Pharmacol. 2020. PMID: 31908574 Free PMC article.
-
Spontaneous regression of metastatic melanoma after inoculation with tetanus-diphtheria-pertussis vaccine.Curr Oncol. 2013 Jun;20(3):e270-3. doi: 10.3747/co.20.1212. Curr Oncol. 2013. PMID: 23737697 Free PMC article.
-
Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by Bordetella pertussis and identification of an immunodominant lipoprotein.Infect Immun. 2004 Jun;72(6):3350-8. doi: 10.1128/IAI.72.6.3350-3358.2004. Infect Immun. 2004. PMID: 15155640 Free PMC article.
-
Induction of polyclonal CD8+ T cell activation and effector function by Pertussis toxin.Cell Immunol. 2011;267(1):50-5. doi: 10.1016/j.cellimm.2010.11.003. Epub 2010 Nov 13. Cell Immunol. 2011. PMID: 21130421 Free PMC article.
-
Effects of a diphtheria-tetanus-acellular pertussis vaccine on immune responses in murine local lymph node and lung allergy models.Clin Vaccine Immunol. 2007 Mar;14(3):211-9. doi: 10.1128/CVI.00306-06. Epub 2007 Jan 3. Clin Vaccine Immunol. 2007. PMID: 17202304 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical